Sex Hormones and Their Relationship with Leptin and Cardiovascular Risk Factors in Pre and Post-Menopausal Nigerian Women with Metabolic Syndrome
Journal Title: Cardiology and Angiology: An International Journal - Year 2015, Vol 3, Issue 3
Abstract
Metabolic Syndrome (MS), which affects 33.1% of Nigerians, predisposing them to cardiovascular disease (CVD) risk, has been associated with the female gender. The cardioprotective effect of oestradiol against CVD is now controversial and was investigated in premenopausal with MS (PRMMS) and postmenopausal women with MS (POMMS). A total of 191 women (44 PRMMS, 126 POMMS and 21 premenopausal women without MS (PRM) (controls) with mean (s.d) age of 40.0 (6.9), 57.0 (8.8), 29.0 (6.8) years were participants of this study. Demography, blood pressure (BP), anthropometry, hormones, fasting plasma glucose (FPG) and lipids were obtained by standard methods. Data were significant at (P<.05). Age, parity, all anthropometric measures, FPG, leptin, ET ratio and FSH were significantly higher while HDLC, testosterone and prolactin were significantly lower in PRMMS compared with controls (P<.03). In comparison of POMMS with PRMMS, age, parity, WHR, systolic BP, TG, FSH and LH were significantly higher while body weight, HC, and leptin were lower in POMMS compared with PRMMS (P<.05). DBP positively predicted oestradiol in PRM only (P=.044) while oestradiol positively predicted testosterone in PRMMS only (P<.001). In POMMS only, DBP positively predicted testosterone; testosterone, ET ratio and FSH positively predicted oestradiol while LDLC and oestradiol positively predicted the ET ratio (P<.03). Metabolic syndrome may predispose both pre and postmenopausal women to the risk cardiovascular disease and type 2 diabetes mellitus. Oestradiol may protect against cardiovascular diseases in women without metabolic syndrome only.
Authors and Affiliations
U. A. Fabian, M. A. Charles-Davies, A. A. Fasanmade, J. A. Olaniyi, O. E. Oyewole, M. O. Owolabi, J. R. Adebusuyi, O. Hassan, B. M. Ajobo, K. Adigun, K. S. Akinlade, O. G. Arinola, E. O Agbedana
Keywords
Related Articles
- EP ID EP344091
- DOI 10.9734/CA/2015/15236
- Views 78
- Downloads 0
Coronary Anomalies: Understanding of Normal Coronary Artery Development for Insight in Treatment of Coronary Artery Disease
Coronary artery anomalies (CAA) are rare congenital abnormalities with incidence of about 1% in the general population.2Unfortunately, despite the low incidence, CAA can cause sudden cardiac death. Identifying the course...
What's New and What Gaps in 2013 European Guidelines for the Management of Arterial Hypertension: A Reappraisal
Arterial hypertension is the most common cardiovascular risk factor causing over 9 million deaths worldwide. Its treatment is crucial in preventing adverse outcomes, in reducing morbidity and mortality and related socio-...
Antioxidant and Radical Scavenging Properties of β-Carotene on Cisplatin Induced Cardiotoxicity
Objective: To investigate the protective role of β-Carotene against cisplatin induced cardiotoxicity in male albino rats. Methods: Various biochemical parameters such as Creatine kinase-MB, Lactate dehydrogenase (LDH), A...
Are Biodegradable Third Generation Drug Eluting Stents the Answer to Instent Restenosis?
The third generation biodegradable Drug Eluting Stent (DES) are being evaluated and being introduced in clinical practice. They have been DESigned to overcome limitations associated with durable polymer and a persistent...
Relationship of Edentulism, Sleep Disordered Breathing and Cardiovascular Disease: NHANES, 2007-2008
Background: Edentulism, though declining in younger adults, remains prevalent in the U.S. older adult population. Poorer health outcomes, including cardiovascular outcomes have been associated with edentulism. Sleep diso...